PRTA Q1 2021 Earnings — Prothena Corporation plc Revenue & Financial Results | Market Cap Arena

PRTAProthena Corporation plc

$549M

Q1 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$160,000+13.5% YoY

Gross Profit

-$21M-13115.0% margin

Operating Income

-$32M-20068.1% margin

Net Income

-$37M-22959.4% margin

EPS (Diluted)

$-0.91

QoQ Revenue Growth

-55.6%

Cash Flow

Operating Cash Flow

-$34M

Free Cash Flow

-$34M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$380M

Total Liabilities

$145M

Stockholders' Equity

$235M

Cash & Equivalents

$343M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$160,000	$141,000	+13.5%
Gross Profit	-$21M	-$15M	-38.9%
Operating Income	-$32M	-$25M	-29.2%
Net Income	-$37M	-$24M	-55.9%

Revenue Segments

Collaboration

$110,00069%

License

$50,00031%